As reported in MDLinx,researchers assessed how preoperative antiviral treatment (AVT) correlates with the incidences of microvascular invasion (MVI) and posthepatectomy early tumor recurrence in hepatitis B virus (HBV)–related hepatocellular carcinoma (HCC). They found that an independent risk factor for MVI was high preoperative HBV DNA level. Following partial hepatectomy for HBV-related HCC, reduced incidences of MVI and early tumor recurrence were reported in relation to antiviral treatment administered more than 90 days before surgery.
Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, China....
Note: If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).